Facchinetti and colleagues present epidemiological evidence regarding comorbidity between menstrual migraine and premenstrual syndrome, and suggest that premenstural symptoms should be incorporated in the diagnostic criteria for menstrual migraine (1). The crux of the matter, however, should be the concern regarding the nature or biological significance of the common neuroendocrine link of transient and cyclic failure of endogenous opioid activity in both premenstrual syndrome and menstrual migraine patients. Is this a primary event of pathogenetic importance (which would merit inclusion in the definition) or the concomitant side effect of a carefully orchestrated adaptive mechanism?
Get full access to this article
View all access options for this article.
References
1.
FacchinettiFNerilIMartignoniEFioroniLNappiGGenazzaniARThe association of menstrual migraine with the premenstrual syndrome.Cephalalgia1993;13:422–5
2.
WelchKMADarnleyDSimkinsRTThe role of estrogen in migraine: a review and hypothesis.Cephalalgia1984;4:227–36
3.
SilbersteinSDMerriamGREstrogens, progestins, and headache.Neurology1991;41:786–93
4.
WintherKHeadmanCPlatelet function and migraine. In:OlesenJEdvinssonL, editors.Basic mechanisms of headache.Amsterdam:Elsevier,1988:301–12
5.
FacchinettiFMartignoniEFioroniLSancesGGenazzaniAROpioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine.Cephalalgia1990;10:51–6
BlauJNMigraine: theories of pathogenesis.Lancet1992;339:1202–7
18.
FacchinettiFMartignoniENappiGFioroniLSancesGGenazzaniARPremenstrual failure of a-adrenergic stimulation on hypothalamus-pituitary responses in menstrual migraine.Psychosom Med1989;51:550–8
19.
KeenanPALindamorLANon-migraine headache across the menstrual cycle in women with and without premenstrual syndrome.Cephalalgia1992;12:356–9
